Expressnews
The 2024 Zhejiang International Trade (India) Exhibition, it started from October 5th and will be going on till 7th Octoberat the Pragati Maidan Convention and Exhibition Center in New Delhi. The main event, the 39th MEDICALL exhibition, is recognized as the premier medical trade show in India and South Asia. It attracted medical manufacturers and providers from countries such as Germany, the United States, Japan, South Korea, and Italy.
The three-day exhibition featured a dedicated Zhejiang area with 70 booths, showcasing 41 companies from cities including Hangzhou, Wenzhou, Jinhua, Yiwu, Shaoxing, Taizhou, Jiaxing, and Huzhou. Exhibits spanned a wide range of products, including medical devices, consumables, in vitro diagnostics, disinfectants, protective equipment, rehabilitation care, traditional medicine, home healthcare, as well as the latest innovations in smart healthcare and medical industry services.
Prominent companies such as Zhejiang Orient Gene Biotech Co., Ltd., Hangzhou Clongene Biotech Co., Ltd., MDK, and Zhejiang Haisheng Medical Device Co., Ltd. showcased their cutting-edge products and technology, highlighting the quality and competitiveness of Zhejiang’s medical manufacturing industry and reinforcing the “Made in Zhejiang” brand image.
Throughout the exhibition, international buyers, distributors, agents, import-export traders, pharmacies, and rehabilitation centers gathered in the Zhejiang exhibition area for trade discussions, negotiations, and potential collaborations.
India’s economy has experienced continued growth in recent years, with significant government investment in healthcare infrastructure. The Indian healthcare market is poised for further expansion, and India ranked among the top ten export destinations for Chinese medical device companies in the first half of 2024. Leveraging its core technological advantages, Zhejiang’s medical and healthcare sector is accelerating its expansion into South Asia. This exhibition provided a valuable platform for Zhejiang enterprises to connect with potential customers, partners, and industry experts in the Indian and broader South Asian markets. It also enabled them to stay abreast of market trends and customer needs, enhancing their competitiveness in India’s medical and healthcare industry.
